1. |
Are you aware about biosimilar? |
Yes |
No |
2. |
Are patients are aware about use of biosimilars in cancer? |
Yes |
No |
3. |
Does patient survival rate increased by use of biosimilars? |
Yes |
No |
4. |
Are biosimilars easily assessable and affordable? |
Yes |
No |
5. |
Biosimilars better option than original drugs? |
Agree |
Disagree |
6. |
Have entry of biosimilars affected the price pattern of reference drugs? |
Yes |
No |
7. |
Is it must for a pharmacist to notify about the prescribes that he or she intends to substitute for a prescribed product? |
Yes |
No |
8. |
Can we see biosimilars replacing original drugs when they lose patents? |
Yes |
No |
9. |
Are you aware about difference between a biosimilar and generic? |
Yes |
No |
10. |
The latest regulation on biosimilars were issued in 2012 |
True |
False |
11. |
Does regulation on biosimilars needs to be updated? |
Yes |
No |
12. |
Does current regulation on biosimilars comply with needs of pharmaceutical industry and patient safety both? |
Yes |
No |
13. |
Does biosimilars have some serious adverse effects? |
Yes |
No |
14. |
Is biosimilars entry into the market a boon? |
True |
False |
15. |
Whether industry is potentially beneficial for biosimilars, exclusive of its five years in the market. |
Yes |
No |
16. |
Whether current regulation supports the industry. |
Yes |
No |
17. |
Does India have clear cut guidelines for naming the biosimilar. |
Yes |
No |
18. |
As per the mission of current government, the single-window system should be followed. |
Yes |
No |
19. |
Is multiple data generation is essential in case of biosimilar. |
Yes |
No |
20. |
As per guidelines, the biosimilar should be compared with approved products or not. |
Agree |
Disagree |
21. |
The comparison should be made with innovator products or the approved products. |
Yes |
No |
22. |
Personal are involved in biosimilar are well trained and qualified or not. |
Yes |
No |
23. |
Is India good in export of biosimilar. |
Agree |
Degree |
24. |
Bridge courses to empower to manpower involved in Biosimilar are utmost necessary. |
Yes |
No |
25. |
Does Govt. of India includes biosimilar in its popular scheme in Ayushman Bharat |
Yes |
No |